Tambotatug Pelitecan Delivers a Major Survival Gain in Relapsed SCLC: TAISHAN-302 Establishes B7-H3 as a Therapeutic Target
FDA Approves Floretyrosine F 18 for PET Imaging in Glioma
Cancer Immunotherapy: 2016 vs 2026
ACT 4 Children Calls for Global Action and Healthcare Equity During Childhood Cancer Awareness Month
Diego A. Díaz-García: PAPILLON Delivers New Overall Survival Data in EGFR Ex20ins NSCLC
Trastuzumab Deruxtecan Improves PFS in First-Line HER2-Mutant NSCLC in DESTINY-Lung04
10 Must-Read Posts In GU Oncology This Week
Jose Pacheco: Tambotatug Pelitecan Shows Superior Survival in Small Cell Lung Cancer
The 28th Annual Blood-Brain Barrier Consortium Meeting, hosted by the Providence Neuroscience Institute, will take place in person on 15–16 October 2026, from 8:00 a.m. to 5:00 p.m. PST, at […]
